Abstract
Objectives: To investigate and quantify the extent to which variations in guidelines influence assessment of control of hypertension. Design: Cross sectional study. Selected patients had hypertension assessed as controlled or uncontrolled with guidelines from New Zealand, Canada, the United States, Britain, and the World Health Organisation. Setting: 18 general practices in Oxfordshire. Subjects: 876 patients with diagnosed hypertension and taking antihypertensive drugs. Main outcome measures: Proportion of patients with controlled hypertension according to each set of guidelines. Results: The proportion of patients with controlled hypertension varied from 17.5% to 84.6% with the different guidelines after adjustment for the sampling method. All five sets of guidelines agreed on the classification for 31% (277) of the patients. The New Zealand guidelines calculate an absolute risk of a cardiovascular event. When this was taken as the standard half of the patients with uncontrolled hypertension by the United States criteria would be treated unnecessarily and 31% of those classified as having controlled hypertension by the Canadian guidelines would be denied beneficial treatment. Conclusions: Hypertension guidelines are inconsistent in their recommendations and need to make clear the absolute benefits and risks of treatment. This study applied the recommendations of guidelines from New Zealand, Canada, the United States, Britain, and the WHO to a sample of 879 hypertensive patients The proportion with controlled hypertension varied between 17.5% and 84.6% according to which set of guidelines was followed Overall, the five sets of guidelines agreed for 31% of the patients Hypertension guidelines are inconsistent and unclear on the absolute benefits of treatment